Cardiotoxicity of chimeric antigen receptor t-cell (car-t) therapy: pathophysiology, clinical implications, and echocardiographic assessment

HIGHLIGHTS

• who: Antonio Nenna et al. from the Saint-Denis, Paris, France have published the research: Cardiotoxicity of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Pathophysiology, Clinical Implications, and Echocardiographic Assessment, in the Journal: (JOURNAL) of 26/05/2022
• what: Considering the clinical benefits of specific anti-IL-6 treatment, recent studies focused on other relevant cytokines involved in CRS.
• future: Reporting remains heterogeneous warranting a standardization of methods and endpoints to allow a detailed comparison in future studies . This review aims to summarize the pathophysiology clinical and of CAR-T-related cardiotoxicity . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.